Atticus Wealth Management »

Moleculin Biotech shares owned by Atticus Wealth Management

Quarter-by-quarter ownership of Moleculin Biotech shares owned by Atticus Wealth Management from 13F filings

Historical chart of Atticus Wealth Management investment in Moleculin Biotech

Tip: Access up to 7 years of quarterly data

All positions including Moleculin Biotech held by Atticus Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moleculin Biotech by Atticus Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $20k 3.3k 5.91

More positions owned by Atticus Wealth Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Neos Etf Trust Neos Enh Inc 1-3 (CSHI)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Ishares Tr Short Treas Bd (SHV)
Ishares Tr S&p 100 Etf (OEF)
Apple (AAPL)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Russell 2000 Etf (IWM)
Microsoft Corporation (MSFT)
Coca-Cola Company (KO)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr Technology (XLK)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)

View all positions for Atticus Wealth Management

Top funds holding Moleculin Biotech

Armistice Capital
Vanguard Group
Geode Capital Management
BlackRock
Atticus Wealth Management
Newbridge Financial Services Group
Tower Research Capital
Morgan Stanley
Fwl Investment Management
Sandy Spring Bank
Advisor Group Holdings
Wells Fargo & Company
North Star Investment Management
Nbc Securities
Royal Bank of Canada

View all funds holding Moleculin Biotech